Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus.

Kidney Int Rep · 2018 · PMC6224662 · PMID 30450457

Europe PMC DOI

hedged sentences

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significanceP = 0.1so close (0.05 < p ≤ 0.1)

Differences between Tac-SM and CsA-SM did not reach statistical significance (RR 5.8 [0.7–46.3]; P = 0.1 for criterion 1; and RR 2.7 [0.8–8.9]; P = 0.1 for criterion 2).

also in 111,027 other papers

a nonsignificant trendno p-value reported

A nonsignificant trend to increased acute graft pyelonephritis and secondary urosepsis was observed in the tacrolimus with SM arm.

also in 5,406 other papers

of borderline significanceno p-value reported

At 3 months, the proportion of patients with PTDM according to criterion 1 or 2 was lower in CsA-SM arm versus Tac-SW and Tac-SM arms, although of borderline significance ( Figure 2 b and c).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.